← Leaderboards
Frank Tufaro
Dnatrix, Inc.
$1,500,000
Attributed
$1,500,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500K · FY2016–18$500K$375K$250K$125K$0
'16
'17
'18
Funding mix
By agency
FDA$1,500,000 · 1
By mechanism
R01$1,500,000 · 1
Top collaborators
No co-investigators on record.
Grant awards (3)
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2018 · FD · contact PI
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2017 · FD · contact PI
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2016 · FD · contact PI